The
global newborn screening market is expected to
reach USD 1.43 billion by 2022, according to a new report by Grand View
Research Inc. Increasing occurrence of congenital disorders that lead to mental
retardation or dysfunctioning body organs and the availability of advanced
screening technologies are expected to drive market growth over the forecast
period.
Furthermore, the market
is expected to witness a boost in demand owing to, the presence of Federal
Bodies involved in organizing awareness and quality assurance programs to
imbibe faith and decrease the number of deaths caused due to negligence &
non-screening. For instance, in 2011, the Ministry of Health, Japan recommended
the use of mass spectrometry in newborn screening and by 2014, the entire
nation started utilizing it for 19 critical conditions.
Full research report on newborn screening market analysis: http://www.grandviewresearch.com/industry-analysis/newborn-screening-market
Further key findings from the report suggest:
·
Tandem
mass spectroscopy is expected to account for over 25% of newborn screening
market share by 2022, owing to its ability to render faster diagnosis and cost
effectiveness.
·
Pulse
oximetry is expected to witness gains of over 9.0% over the forecast period.
Masimo’s Eve software and Radical-7 oximeter gained CE marking in 2014 leading
to a growth in demand supported by quality assurance and better analysis.
·
Dry
blood spot test is expected to witness lucrative growth over the forecast
period. Free distribution of filter paper by government is expected to boost
the primary screening of all newborns, thereby, accelerating market growth.
·
Presently,
100% screening of over 4 million neonates is carried out in the North America
annually. Encouraging efforts to prevent long term disabilities by healthcare
providers and government agencies are some vital factors influencing regional
market growth. Presence of favorable reimbursement policies reduces the burden
of treatment cost, thereby, promoting higher procedure volumes
·
Asia
Pacific newborn screening market is expected to witness the fastest growth of
over 11.0% during the forecast period. This growth is attributed to the
presence of large untapped opportunities, rising healthcare expenditure levels,
increasing disease prevalence rate, and the introduction of supportive
government initiatives.
·
Some
key players of this market include Agilent Technologies Inc., AB Sciex LLC,
Natus Medical Inc., PerkinElmer Inc., Covidien Plc, Masimo Corp., Trivitron
Healthcare, Bio-Rad Laboratories Inc. GE Healthcare and Waters Corp.
·
Market
participants are constantly engaged in developing technologically advanced
products in an attempt to improve presence and ensure sustainability.
PerkinElmer’s “EnLite Neonatal TREC Kit” gained FDA approval in 2014 for the
diagnosis and treatment of Severe Combined Immunodeficiency Disease (SCID)
leading to replacement of non-approved tests in certain states of the U.S.
·
Over
20 states along with the Navajo Nation and the District of Columbia have put
screening programs into practice for the same.
View more reports of this category by Grand
View Research at: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has
segmented the global newborn screening market on the basis of product,
technology, test type and region:
Product
Outlook (Revenue, USD Million, 2012 - 2022)
·
Instruments
·
Reagents
& Assay Kits
Technology
Outlook (Revenue, USD Million, 2012 - 2022)
·
Tandem
Mass Spectrometry
·
Pulse
Oximetry
·
Enzyme
Based Assays
·
DNA
Assays
·
Electrophoresis
Test
Outlook (Revenue, USD Million, 2012 - 2022)
·
Dry
Blood Spot Test
·
Critical
Congenital Heart Disease (CCHD)
·
Hearing
Screen
Regional
Outlook (Revenue, USD Million, 2012 - 2022)
·
North
America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
o
France
o
Rest
of Europe
·
Asia
Pacific
o
Japan
o
China
o
India
o
Rest
of Asia Pacific
·
Latin
America
o
Brazil
o
Mexico
o
Rest
of Latin America
·
Middle
East and Africa (MEA)
o
South
Africa
o
Rest
of Middle East and Africa
Access
press release by Grand View Research: https://www.grandviewresearch.com/press-release/global-newborn-screening-market
About
Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
